Mirari Marquez Cid

Title: Mirari Marquez Cid: Innovator in Cancer Diagnosis

Introduction

Mirari Marquez Cid is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer diagnosis through her innovative research and development of biomarker proteins. Her work focuses on improving diagnostic methods for bladder cancer, which can lead to better patient outcomes.

Latest Patents

Mirari holds a patent for her invention titled "Bladder cancer biomarker proteins." This invention relates to a collection of signature peptides representing at least 10 proteins that are utilized for cancer diagnosis and prognosis. The patent also includes an artificial protein comprising these signature peptides and a nucleic acid construct encoding for such an artificial protein. Furthermore, her invention outlines a method for cancer diagnosis that involves analyzing at least 10 proteins in a urine sample from a subject. Additionally, it encompasses an immunoassay product that includes antibodies for detecting these proteins.

Career Highlights

Throughout her career, Mirari has worked with notable organizations, including Polyquant GmbH and Commissariat à l'Énergie Atomique et aux Énergies Alternatives. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her coworkers include Jerome Garin and Christophe Masselon. Their collaboration has further enhanced the impact of her work in cancer diagnostics.

Conclusion

Mirari Marquez Cid is a trailblazer in the field of cancer diagnosis, with her innovative patent contributing to advancements in medical technology. Her dedication to improving diagnostic methods showcases the importance of innovation in healthcare.